Stay alert, beware of scamsters - know more

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open1,114
High1,122.9
Low1,095
Prev. Close1,114.1
Avg. Traded Price1,109.2
Volume2,244

MARKET DEPTH

info2
Total bid5836.00
Total ask4962.00
OrdersQtyBid
1501092.5
131091.3
261091.2
151091.1
111091
AskQtyOrders
1094.915
1095182
1095.524
1095.618
1095.929

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1080.303 days ago
1145.603 days ago
arrow

LOWER/UPPER CIRCUITS

865.70
1298.50
arrow
Ttk Healthcare Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral

Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 16.85%
Net profit growth 5Y CAGR : 20.85%

About TTK Healthcare Limited

TTK Healthcare Limited is a public limited company incorporated on May 21, 1958, and is part of the TTK Group. The company is registered with its office at No.6, Cathedral Road, Chennai, and its equity shares are listed on BSE and NSE in India. It manufactures, markets, and distributes a broad portfolio covering five Strategic Business Units (SBUs): Pharmaceuticals (Animal Welfare), Consumer Products, Medical Devices, Foods, and Protective Devices (male contraceptives). The company operates 8 plants and 37 offices across India, serving all 28 states and 8 union territories, and exports to 54 countries, with exports accounting for 10.66% of its turnover. Key product brands include EVA cosmetics, Woodward’s Gripe Water, Good Home scrubbers and air fresheners, artificial heart valves, orthopedic implants, and male contraceptives.

 

TTK Healthcare Limited has no subsidiaries or joint ventures. The Board’s Report confirms the absence of subsidiary companies.

Key Milestones of TTK Healthcare Limited

  • Completed sale/transfer of the Human Pharma Division effective May 9, 2022.
  • Continued technology upgrades and automation across sales, finance, and production processes in the latest year.
  • Board approved the annual financial statements on May 23, 2025.

TTK Healthcare Limited Business Segment

The company operates in a single integrated business segment encompassing manufacturing, marketing, and distribution of pharmaceuticals, consumer products, medical devices, foods, and protective devices, serving domestic and international markets.

Product Mix (% of total turnover):

  • Male Contraceptives: 25.78%
  • Food Products: 16.60%
  • Animal Welfare Products: 15.77%
  • Ayurvedic Preparations: 12.50%
  • Medical Devices: 11.25%
  • Home Care Products: 9.32%
  • Cosmetics and Deodorant: 8.73%

Geography:

  • India: 89.34%
  • Exports: 10.66%

TTK Healthcare Limited Key Management

  • T.T. Raghunathan – Executive Chairman
  • S Kalyanaraman – Managing Director & CEO
  • B V K Durga Prasad – President – Finance (CFO)
  • Gowry A Jaishankar – DGM – Legal & Company Secretary
  • S Ranganath Rao – President – Foods Division
  • Brijj Balaji Singh – President – Protective Devices Division
  • Yogesh Yadav – President – Consumer Products Division

Latest Updates on TTK Healthcare Limited

  • Continued operation of five SBUs and undertook technology upgrades including Oracle APEX rollout and digital tool deployments across sales, order tracking, surgery tracking, and expense management integrated with Oracle EBS.
  • Incurred capital expenditure of Rs.14.33 crore including equipment for Protective Devices and Foods divisions.
  • Recorded profit on sale of leasehold land with building at Mahindra World City, Chennai; wrote off finished goods related to male contraceptives following USAID Stop Work Order.
  • Board inducted three new directors and saw retirement of two directors during the year; appointed a new Company Secretary effective June 1, 2024.
  • Paid regulatory fines related to delayed appointment of a Woman Director and filed appeals.
  • Approved the appointment of Cost Auditors for the ensuing year subject to member ratification.
personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

The intraday low for Ttk Healthcare Ltd on the NSE today was ₹1,080.30. The stock's 52-week low stands at ₹735.00, recorded on 30 Mar 2026. Today's low is 46.98% above the 52-week low, indicating the stock is trading well above its yearly lows.

As of 22 Aug 2026, the share price of Ttk Healthcare Ltd is ₹1,105.00 on the NSE and ₹1,110.00 on the BSE. The stock opened at ₹1,082.10, touched a high of ₹1,145.60 and a low of ₹1,080.30 during today's session.

Over the last 6 months, Ttk Healthcare Ltd has given a return of 17.06%. The stock was priced at ₹924.40 on 23 Feb 2026 and has Rise to ₹1,105.00 as of 22 Aug 2026, a change of ₹180.60 per share.

Yes,Ttk Healthcare Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 50.00 per share between FY2022 and FY2026, with the most recent dividend of ₹10.00 per share for Jun 26, with an ex-dividend date of 17 Jul 2026. At the current market price of ₹1,105.00, the trailing dividend yield of Ttk Healthcare Ltd stands at 20.00%.

The all-time high (ATH) for Ttk Healthcare Ltd was ₹1,843.10, recorded on 09 Sep 2024. At the current price of ₹1,105.00, the stock is trading 40.05% below its all-time high. The all-time low recorded was ₹252.35 on 31 Mar 2010.

For Q1 FY27, Ttk Healthcare Ltd reported: Revenue (Net Sales): ₹2575.57 Cr - Up 18.15% year-on-year from ₹2179.85 Cr in Q4 FY26. Net Income (PAT): ₹212.78 Cr - Down -2.22% year-on-year from ₹217.62 Cr in Q4 FY26.

Ttk Healthcare Ltd has delivered a return of 21.66% over the last 3 months. The stock was trading at ₹889.45 on 22 May 2026 and is currently at ₹1,105.00 as of 22 Aug 2026, reflecting a Gain of ₹215.55 per share over this period.

The intraday high for Ttk Healthcare Ltd on the NSE today (22 Aug 2026) was ₹1,145.60. This compares to the 52-week high of ₹1,216.80 recorded on 29 Aug 2025. Today's high was -5.85% below the 52-week high.

Ttk Healthcare Ltd has delivered -5.64% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,216.80 on 29 Aug 2025 and a 52-week low of ₹735.00 on 30 Mar 2026. It is currently trading at ₹1,105.00 as of 22 Aug 2026.

Ttk Healthcare Ltd has delivered a 61.42% absolute return over the past 5 years, equivalent to a CAGR of 10.05% per annum. The stock was priced at ₹684.55 in Aug 2021 and has risen to ₹1,105.00 as of 22 Aug 2026. An investment of ₹1,00,000 in Ttk Healthcare Ltd five years ago would be worth ₹1,61,420.00 today.

+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91